Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2009 1
2010 1
2011 2
2012 3
2013 9
2014 3
2015 10
2016 11
2017 7
2018 9
2019 4
2020 11
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

68 results
Results by year
Filters applied: . Clear all
Page 1
Management of borderline ovarian tumors.
du Bois A, Trillsch F, Mahner S, Heitz F, Harter P. du Bois A, et al. Among authors: trillsch f. Ann Oncol. 2016 Apr;27 Suppl 1:i20-i22. doi: 10.1093/annonc/mdw090. Ann Oncol. 2016. PMID: 27141065 Free article. Review.
Sirtuin1 expression and survival in endometrial and clear-cell uterine cancer.
Beyer S, Chen F, Meister S, Czogalla B, Kolben TM, Hester A, Burges A, Trillsch F, Schmöckel E, Mayr D, Mayerhofer A, Mahner S, Jeschke U, Kolben T. Beyer S, et al. Among authors: trillsch f. Histochem Cell Biol. 2020 Aug;154(2):189-195. doi: 10.1007/s00418-020-01873-x. Epub 2020 May 9. Histochem Cell Biol. 2020. PMID: 32388637 Free PMC article.
EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer.
Czogalla B, Kuhn C, Heublein S, Schmöckel E, Mayr D, Kolben T, Trillsch F, Burges A, Mahner S, Jeschke U, Hester A. Czogalla B, et al. Among authors: trillsch f. J Cancer Res Clin Oncol. 2019 Oct;145(10):2519-2527. doi: 10.1007/s00432-019-03017-8. Epub 2019 Sep 4. J Cancer Res Clin Oncol. 2019. PMID: 31485769
Systemic treatment of vulvar cancer.
Mahner S, Prieske K, Grimm D, Trillsch F, Prieske S, von Amsberg G, Petersen C, Mueller V, Jaenicke F, Woelber L. Mahner S, et al. Among authors: trillsch f. Expert Rev Anticancer Ther. 2015 Jun;15(6):629-37. doi: 10.1586/14737140.2015.1037837. Epub 2015 May 21. Expert Rev Anticancer Ther. 2015. PMID: 25997120 Review.
Cytoplasmic VDR expression as an independent risk factor for ovarian cancer.
Czogalla B, Deuster E, Liao Y, Mayr D, Schmoeckel E, Sattler C, Kolben T, Hester A, Fürst S, Burges A, Mahner S, Jeschke U, Trillsch F. Czogalla B, et al. Among authors: trillsch f. Histochem Cell Biol. 2020 Oct;154(4):421-429. doi: 10.1007/s00418-020-01894-6. Epub 2020 Jun 22. Histochem Cell Biol. 2020. PMID: 32572587 Free PMC article.
Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology.
Czogalla B, Kahaly M, Mayr D, Schmoeckel E, Niesler B, Hester A, Zeder-Göß C, Kolben T, Burges A, Mahner S, Jeschke U, Trillsch F. Czogalla B, et al. Among authors: trillsch f. Cancer Manag Res. 2019 Aug 14;11:7673-7684. doi: 10.2147/CMAR.S210004. eCollection 2019. Cancer Manag Res. 2019. PMID: 31616183 Free PMC article.
Adjuvant therapy in node-positive vulvar cancer.
Mahner S, Trillsch F, Kock L, Rohsbach D, Petersen C, Kruell A, Harter P, Jaenicke F, Woelber L. Mahner S, et al. Among authors: trillsch f. Expert Rev Anticancer Ther. 2013 Jul;13(7):839-44. doi: 10.1586/14737140.2013.811063. Expert Rev Anticancer Ther. 2013. PMID: 23875662 Review.
68 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page